Katalyst Healthcares and Life Sciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Katalyst HLS is a private, revenue-generating services firm operating as a specialized CRO and regulatory consultant. It offers a comprehensive suite of integrated services spanning clinical trial operations (Phases I-IV), data management, statistical analysis, and regulatory submissions, adhering to global quality standards like GCP, GLP, GMP, and ICH guidelines. The company differentiates itself through a structured, five-step methodology emphasizing precision, compliance, and scientific integrity to streamline client product development. Its target market includes a broad range of life science sectors, positioning it to capitalize on the growing outsourcing trend in clinical research and regulatory affairs.

Drug DeliveryDigital Health

Technology Platform

Integrated, five-step service methodology for clinical research and regulatory affairs, emphasizing compliance (GCP/GLP/GMP/ICH), data management (EDC/eClinical), and end-to-end project execution from planning to submission.

Opportunities

The growing trend of outsourcing in pharma and biotech R&D, especially among small and mid-sized companies, presents a sustained demand for CRO services.

Expansion into digital health tools and data analytics, alongside serving emerging markets like India (CDSCO), offers avenues for service diversification and growth.

Risk Factors

Faces intense competition from large global CROs and niche players, risking pricing pressure and client attrition.

Operational performance is critical; any significant compliance failure or project error could severely damage reputation and client trust.

Revenue is subject to cyclicality and dependence on a fluctuating client project pipeline.

Competitive Landscape

Operates in the highly fragmented and competitive global CRO and regulatory consulting market. Competes with large, full-service CROs (e.g., IQVIA, Labcorp, Parexel) with greater scale and resources, as well as numerous small to mid-sized specialized firms. Differentiation is based on service quality, therapeutic expertise, regulatory acumen, and client relationships rather than proprietary technology.

More companies in Digital Health & Biotech SaaS →More companies in United States →